Media

Support Of Industry Underscores Pro-Business Commitment
2014 Livestock Biotech Summit three day programming touched on issues such as engaging consumers, animal welfare, the promise of the technology.

Press Releases

Dec 20 1999
WASHINGTON, D.C. (Dec. 20, 1999) -- Dr. Judah Folkman, who discovered the process of tumor angiogenesis, and Dr. Jurgen Drews, former president of global...
Dec 7 1999
WASHINGTON, D.C. (Dec. 7, 1999) -- The Biotechnology Industry Organization (BIO) will present alternatives to proposed guidelines for reporting adverse patient...
Dec 6 1999
(Carl Feldbaum, president of BIO, today issued the following statement upon the death of Bob Swanson, co-founder of Genentech): Washington, D.C. (December 6,...
Nov 24 1999
(Carl B. Feldbaum, president of the Biotechnology Industry Organization, issued the following statement prior to the start of the World Trade Organization's...
Nov 23 1999
See Senate Resolution 200 below WASHINGTON, D.C. (Nov. 23, 1999) -- The Biotechnology Industry Organization (BIO) applauds the U.S. Senate for its adoption of...
Nov 22 1999
WASHINGTON, D.C. (Nov. 22, 1999) -- Included in the 2000 budget legislation passed by Congress are three measures that give a major boost to the biotechnology...
Nov 18 1999
The Biotechnology Industry Organization (BIO) is pleased to be invited by the Food and Drug Administration (FDA) to participate on the Food Safety Panel for...
Nov 18 1999
Thank you for inviting the Biotechnology Industry Organization (BIO) to provide a statement on the Food and Drug Administration's policy on information issues...
Nov 16 1999
WASHINGTON, D.C. (Nov. 16, 1999) -- The Biotechnology Industry Organization (BIO) fully concurs with the U.S. Food and Drug Administration's (FDA) initiative...


Biotechnology News

October 1, 2014

SAN DIEGO--(BUSINESS WIRE)--Ignyta, Inc. (Nasdaq: RXDX), an oncology precision medicine biotechnology company, announced today that it has secured a $31 million term loan...

October 1, 2014

CAMBRIDGE, Mass.--(BUSINESS WIRE)--Stemgent Inc. announced today that it has completed the sale of its stem cell reagents and services business to ReproCELL in a cash...

October 1, 2014

ANN ARBOR, Mich.--(BUSINESS WIRE)--Esperion Therapeutics, Inc. (NASDAQ: ESPR), an emerging pharmaceutical company focused on developing and commercializing first-in-class...

October 1, 2014

SANTA CLARA, Calif.--(BUSINESS WIRE)--Affymetrix, Inc. (NASDAQ: AFFX) today announced that it will report operating results for the third quarter of 2014 after market...

October 1, 2014

WILLOW GROVE, Pa.--(BUSINESS WIRE)--New Article highlights a more Effective Method for Analyzing Sexual Assault Evidence